Mahindra Manulife Mid Cap Fund
The scheme seeks to generate long term capital appreciation & provide long-term growth opportunities by investing in a portfolio constituted of equity & equity related securities and derivatives predominantly in mid cap companies.
Growthvine rating: 4/5 — ranked #4 of 33 in category.
Fund basics
| Category | Equity: Mid Cap |
|---|
| NAV | ₹36.05 (as of 2026-09-11) |
|---|
| AUM | ₹5,076 Cr |
|---|
| Expense ratio | 1.60% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Kirti Dalvi |
|---|
| Exit load | 1% for redemption within 3 months |
|---|
Performance & risk
| 5-year annualised return | 17.49% |
|---|
| Sharpe ratio | 0.8 |
|---|
| Standard deviation | 17.28% |
|---|
| Max drawdown | -33.21% |
|---|
| Alpha | 2.69 |
|---|
| Beta | 0.95 |
|---|
Over 5 years, captured 97.6% of NIFTY Midcap 150's upside and 93.7% of its downside.
Market cap allocation
| Large cap | 6.0% |
|---|
| Mid cap | 79.3% |
|---|
| Small cap | 14.7% |
|---|
Concentration
| Top 5 holdings | 15.0% |
|---|
| Top 10 holdings | 26.8% |
|---|
| Total holdings | 55 |
|---|
| Index overlap | 29.8% |
|---|
| Active share | 70.2% |
|---|
Top holdings
- Federal Bank Ltd. — 3.8%
- IndusInd Bank Ltd. — 3.5%
- NIPPON LIFE INDIA ASSET MANAGEMENT LIMITED — 2.6%
- L&T Finance Limited — 2.6%
- COFORGE LIMITED — 2.5%
- Aditya Birla Capital Ltd — 2.5%
- Triparty Repo — 2.4%
- Glenmark Pharmaceuticals ltd — 2.4%
- KEI Industries Ltd. — 2.3%
- AIA Engineering Ltd. — 2.3%
Top sectors
- Banking & Financial — 18.9%
- Industrial Products — 11.1%
- Automobile — 9.6%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 6.6% | Q2 | #11 of 31 |
| 2025 | 1.2% | Q3 | #18 of 29 |
| 2024 | 29.3% | Q2 | #13 of 29 |
| 2023 | 47.0% | Q1 (Top) | #2 of 28 |
| 2022 | 0.2% | Q3 | #16 of 22 |